Filing Details
- Accession Number:
- 0000914190-21-000374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-24 16:30:53
- Reporting Period:
- 2021-09-22
- Accepted Time:
- 2021-09-24 16:30:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739054 | Kim Kelderman | 614 Mckinley Place Ne Minneapolis MN 55413 | Pres. Diagnostics & Genom | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-22 | 822 | $529.04 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $150.78 | 2025-05-01 | 2,652 | 2,652 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $150.78 | 2025-05-01 | 7,348 | 7,348 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $177.32 | 2025-08-08 | 12,044 | 12,044 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $177.32 | 2025-08-08 | 9,033 | 9,033 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,363 | 2,363 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $190.41 | 2026-08-07 | 11,961 | 11,961 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $190.41 | 2026-08-07 | 15,948 | 15,948 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,015 | 2,015 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 8,991 | 8,991 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 11,988 | 11,988 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 8,325 | 8,325 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 8,325 | 8,325 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 1,245 | 1,245 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $481.82 | 2028-08-06 | 4,864 | 4,864 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $481.82 | 2028-08-06 | 6,486 | 6,486 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-05-01 | 2,652 | 2,652 | Direct |
| 2025-05-01 | 7,348 | 7,348 | Direct |
| 2025-08-08 | 12,044 | 12,044 | Direct |
| 2025-08-08 | 9,033 | 9,033 | Direct |
| 2,363 | 2,363 | Direct | |
| 2026-08-07 | 11,961 | 11,961 | Direct |
| 2026-08-07 | 15,948 | 15,948 | Direct |
| 2,015 | 2,015 | Direct | |
| 2027-08-05 | 8,991 | 8,991 | Direct |
| 2027-08-05 | 11,988 | 11,988 | Direct |
| 2027-08-05 | 8,325 | 8,325 | Direct |
| 2027-08-05 | 8,325 | 8,325 | Direct |
| 1,245 | 1,245 | Direct | |
| 2028-08-06 | 4,864 | 4,864 | Direct |
| 2028-08-06 | 6,486 | 6,486 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
- Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
- Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
- Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
- Fully exercisable.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
- Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
- Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
- Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
- Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.
Billionaire Hedge Funds
